Skip to main content

Table 2 Deep-vein thrombosis prophylaxis type in ischemic stroke patients during hospitalization and in the 14-day period post-discharge

From: Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States

 

Patients (n = 1524)

Index hospitalization, n (%)

 

Received any prophylaxis

703 (46.1)

  Pharmacological prophylaxis

591 (38.8)

   Unfractionated heparin

431 (28.3)

   Enoxaparin

174 (11.4)

   Dalteparin

1 (0.1)

   Tinzaparin

0

   Fondaparinux

1 (0.1)

   Warfarin

0

  Combination prophylaxisa

153 (10.0)

  Mechanical prophylaxis

187 (12.3)

   Graduated compression stockings

60 (3.9)

   Non-graduated compression stockings

148 (9.7)

Outpatient, n (%)

 

Received any prophylaxis

98 (6.4)

  Pharmacological prophylaxis

98 (6.4)

   Unfractionated heparin

0

   Enoxaparin

27 (1.8)

   Dalteparin

0

   Tinzaparin

0

   Fondaparinux

0

   Warfarin

90 (5.9)

  Combination pharmacological prophylaxisb

19 (1.3)

  1. aUse of more than one product/type of prophylaxis across the entire duration of the hospitalization.
  2. bUse of more than one anticoagulant in the outpatient setting.